These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19275700)

  • 21. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.
    Levin MJ; Bacon TH; Leary JJ
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S248-57. PubMed ID: 15494896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
    Tan HH; Goh CL
    Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marine organisms as a therapeutic source against herpes simplex virus infection.
    Vo TS; Ngo DH; Ta QV; Kim SK
    Eur J Pharm Sci; 2011 Sep; 44(1-2):11-20. PubMed ID: 21782018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes simplex virus infection.
    Whitley RJ
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses.
    Toscani A; Denaro R; Pacheco SFC; Biolatti M; Anselmi S; Dell'Oste V; Castagnolo D
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EBV-related lymphomas: new approaches to treatment.
    Kanakry JA; Ambinder RF
    Curr Treat Options Oncol; 2013 Jun; 14(2):224-36. PubMed ID: 23549980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors.
    Kerr JR
    J Clin Pathol; 2019 Oct; 72(10):651-658. PubMed ID: 31315893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Herpes simplex virus resistance to antivirals].
    Burrel S; Topalis D; Boutolleau D
    Virologie (Montrouge); 2020 Oct; 24(5):325-342. PubMed ID: 33111706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
    Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antiviral effect of novel purine conjugate LAS-131 against Herpes simplex virus type 1 (Herpesviridae: Alphaherpesvirinae: Simplexvirus: Human alphaherpesvirus 1) in vitro].
    Andronova VL; Galegov GA; Musiyak VV; Vozdvizhenskaya OA; Levit GL; Krasnov VP
    Vopr Virusol; 2021 Jan; 65(6):373-380. PubMed ID: 33533233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral treatment of Epstein-Barr virus-associated lymphoproliferations.
    Oertel SH; Riess H
    Recent Results Cancer Res; 2002; 159():89-95. PubMed ID: 11785848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
    Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
    J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral Active Compounds Derived from Natural Sources against Herpes Simplex Viruses.
    van de Sand L; Bormann M; Schmitz Y; Heilingloh CS; Witzke O; Krawczyk A
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes simplex virus type-1: replication, latency, reactivation and its antiviral targets.
    Pires de Mello CP; Bloom DC; Paixão IC
    Antivir Ther; 2016; 21(4):277-86. PubMed ID: 26726828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives.
    Schalkwijk HH; Snoeck R; Andrei G
    Biochem Pharmacol; 2022 Dec; 206():115322. PubMed ID: 36309081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA viruses (CMV, EBV, and the herpesviruses).
    Zamora MR
    Semin Respir Crit Care Med; 2011 Aug; 32(4):454-70. PubMed ID: 21858750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.
    Cheng YC; Huang ES; Lin JC; Mar EC; Pagano JS; Dutschman GE; Grill SP
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2767-70. PubMed ID: 6302704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
    Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
    Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.